Less aggressive surgery and radiotherapy is the way forward

Alberto Costa, Stefano Zurrida, Giovanna Gatti, Wolfgang Gatzemeier, Roberto Orecchia, Simonetta Monti, Lea Regolo, Alberto Luini

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Purpose of review: Conserving the breast is one of the main objectives in treating patients affected by carcinoma. This objective should be compatible with good local control to keep the risk of local failures low. The progressive reduction of the extension of surgery in the breast and in the axilla is now accompanied by a reduction of the radiation field. This article provides an update on conservative therapy for breast cancer. Recent findings: After the development of quadrantectomy, the effectiveness of sentinel node biopsy was demonstrated in the axillary staging of breast carcinoma. The situation took another step forward with partial breast irradiation. The highest incidence of local relapse after breast-conserving surgery is observed in the same area as the primary tumor. This factor provides the rationale for reducing the radiation field to a limited area of the breast primarily affected by carcinoma. Summary: The Milan I trial on breast conservative surgery provided definitive confirmation of the equivalence of quadrantectomy, followed by radiotherapy, to mastectomy in terms of local control of disease. The randomized trial on sentinel node biopsy demonstrated the effectiveness of this procedure in axillary staging of breast carcinoma. Radiotherapy is currently under investigation in terms of limiting the radiation field to the affected quadrant of the breast by means of various techniques.

Original languageEnglish
Pages (from-to)523-528
Number of pages6
JournalCurrent Opinion in Oncology
Volume16
Issue number6
DOIs
Publication statusPublished - Nov 2004

Fingerprint

Breast
Radiotherapy
Radiation
Breast Neoplasms
Carcinoma
Biopsy
Axilla
Segmental Mastectomy
Mastectomy
Recurrence
Incidence
Neoplasms
cyhalothrin

Keywords

  • Breast carcinoma
  • Conservative surgery
  • Local control
  • Partial breast irradiation

ASJC Scopus subject areas

  • Cancer Research

Cite this

Less aggressive surgery and radiotherapy is the way forward. / Costa, Alberto; Zurrida, Stefano; Gatti, Giovanna; Gatzemeier, Wolfgang; Orecchia, Roberto; Monti, Simonetta; Regolo, Lea; Luini, Alberto.

In: Current Opinion in Oncology, Vol. 16, No. 6, 11.2004, p. 523-528.

Research output: Contribution to journalArticle

Costa, Alberto ; Zurrida, Stefano ; Gatti, Giovanna ; Gatzemeier, Wolfgang ; Orecchia, Roberto ; Monti, Simonetta ; Regolo, Lea ; Luini, Alberto. / Less aggressive surgery and radiotherapy is the way forward. In: Current Opinion in Oncology. 2004 ; Vol. 16, No. 6. pp. 523-528.
@article{a3c0e8054a0d4c14b03c48c2d80b7fe7,
title = "Less aggressive surgery and radiotherapy is the way forward",
abstract = "Purpose of review: Conserving the breast is one of the main objectives in treating patients affected by carcinoma. This objective should be compatible with good local control to keep the risk of local failures low. The progressive reduction of the extension of surgery in the breast and in the axilla is now accompanied by a reduction of the radiation field. This article provides an update on conservative therapy for breast cancer. Recent findings: After the development of quadrantectomy, the effectiveness of sentinel node biopsy was demonstrated in the axillary staging of breast carcinoma. The situation took another step forward with partial breast irradiation. The highest incidence of local relapse after breast-conserving surgery is observed in the same area as the primary tumor. This factor provides the rationale for reducing the radiation field to a limited area of the breast primarily affected by carcinoma. Summary: The Milan I trial on breast conservative surgery provided definitive confirmation of the equivalence of quadrantectomy, followed by radiotherapy, to mastectomy in terms of local control of disease. The randomized trial on sentinel node biopsy demonstrated the effectiveness of this procedure in axillary staging of breast carcinoma. Radiotherapy is currently under investigation in terms of limiting the radiation field to the affected quadrant of the breast by means of various techniques.",
keywords = "Breast carcinoma, Conservative surgery, Local control, Partial breast irradiation",
author = "Alberto Costa and Stefano Zurrida and Giovanna Gatti and Wolfgang Gatzemeier and Roberto Orecchia and Simonetta Monti and Lea Regolo and Alberto Luini",
year = "2004",
month = "11",
doi = "10.1097/01.cco.0000142483.04720.b5",
language = "English",
volume = "16",
pages = "523--528",
journal = "Current Opinion in Oncology",
issn = "1040-8746",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Less aggressive surgery and radiotherapy is the way forward

AU - Costa, Alberto

AU - Zurrida, Stefano

AU - Gatti, Giovanna

AU - Gatzemeier, Wolfgang

AU - Orecchia, Roberto

AU - Monti, Simonetta

AU - Regolo, Lea

AU - Luini, Alberto

PY - 2004/11

Y1 - 2004/11

N2 - Purpose of review: Conserving the breast is one of the main objectives in treating patients affected by carcinoma. This objective should be compatible with good local control to keep the risk of local failures low. The progressive reduction of the extension of surgery in the breast and in the axilla is now accompanied by a reduction of the radiation field. This article provides an update on conservative therapy for breast cancer. Recent findings: After the development of quadrantectomy, the effectiveness of sentinel node biopsy was demonstrated in the axillary staging of breast carcinoma. The situation took another step forward with partial breast irradiation. The highest incidence of local relapse after breast-conserving surgery is observed in the same area as the primary tumor. This factor provides the rationale for reducing the radiation field to a limited area of the breast primarily affected by carcinoma. Summary: The Milan I trial on breast conservative surgery provided definitive confirmation of the equivalence of quadrantectomy, followed by radiotherapy, to mastectomy in terms of local control of disease. The randomized trial on sentinel node biopsy demonstrated the effectiveness of this procedure in axillary staging of breast carcinoma. Radiotherapy is currently under investigation in terms of limiting the radiation field to the affected quadrant of the breast by means of various techniques.

AB - Purpose of review: Conserving the breast is one of the main objectives in treating patients affected by carcinoma. This objective should be compatible with good local control to keep the risk of local failures low. The progressive reduction of the extension of surgery in the breast and in the axilla is now accompanied by a reduction of the radiation field. This article provides an update on conservative therapy for breast cancer. Recent findings: After the development of quadrantectomy, the effectiveness of sentinel node biopsy was demonstrated in the axillary staging of breast carcinoma. The situation took another step forward with partial breast irradiation. The highest incidence of local relapse after breast-conserving surgery is observed in the same area as the primary tumor. This factor provides the rationale for reducing the radiation field to a limited area of the breast primarily affected by carcinoma. Summary: The Milan I trial on breast conservative surgery provided definitive confirmation of the equivalence of quadrantectomy, followed by radiotherapy, to mastectomy in terms of local control of disease. The randomized trial on sentinel node biopsy demonstrated the effectiveness of this procedure in axillary staging of breast carcinoma. Radiotherapy is currently under investigation in terms of limiting the radiation field to the affected quadrant of the breast by means of various techniques.

KW - Breast carcinoma

KW - Conservative surgery

KW - Local control

KW - Partial breast irradiation

UR - http://www.scopus.com/inward/record.url?scp=8344284312&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8344284312&partnerID=8YFLogxK

U2 - 10.1097/01.cco.0000142483.04720.b5

DO - 10.1097/01.cco.0000142483.04720.b5

M3 - Article

C2 - 15627012

AN - SCOPUS:8344284312

VL - 16

SP - 523

EP - 528

JO - Current Opinion in Oncology

JF - Current Opinion in Oncology

SN - 1040-8746

IS - 6

ER -